Search results
AusperBio secures funding to advance AHB-137 for CHB
Pharmaceutical Technology· 23 hours agoAusperBio previously gained breakthrough therapy designation in China for AHB-137...Evaluation], we are well-positioned to rapidly advance the clinical...
'Kejriwal lost only 2 kg and not...': Tihar authorities counter AAP's claims
Business Today· 23 hours agoTihar jail authorities on Monday said that Arvind Kejriwal has only lost 2 kg in prison and is being...
Chandipura virus in Gujarat: Symptoms, causes - all you need to know
Business Today· 23 hours agoGujarat Health Minister Rushikesh Patel on Monday said there was no need to be scared but "we need...
How a cancer care centre in Gujarat is enhancing the quality of patients’ lives with home care and...
Indian Express· 23 hours agoA partly government-run institution, it provides palliative care, which is holistic therapy and ...
ORS misconception: Is it only for children? Drinking plain water is just as effective as ORS?
CNBC Awaaz· 23 hours agoOral Rehydration Solution (ORS) is a mixture of salts and sugar dissolved in clean water, used to...
Sirnaomics completes IND-enabling trials of siRNA therapy STP125G
Clinical Trials Arena· 24 hours ago“Those data readouts further validated STP125G as a novel siRNA therapeutic candidate for the ...
Mabwell’s 9MW2821 gains FDA fast track status for breast cancer
Pharmaceutical Technology· 24 hours agoOne subject had been in complete response for 20 months. The company has 14 pipeline products - 10...
Alembic Pharmaceuticals gets tentative nod from USFDA for generic Selexipag injection
CNBC Awaaz· 1 day agoAlembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health...
Alembic secures FDA tentative approval for Selexipag Injection - ET HealthWorld | Pharma
The Economic Times· 1 day agoSelexipag Injection: The approved ANDA is therapeutically equivalent to the reference listed drug...
AstraZeneca’s Tagrisso gains approval in Canada for NSCLC
Pharmaceutical Technology· 1 day agoThe approval is intended for the first-line treatment of patients with locally advanced or...